Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease—a review

Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease—a review

Summary Duration and compostion of dual antiplatelet therapy has been increasingly changed within the past few years as also indicated in the firmer ESC guidelines. The current manuscript summarizes the most important changes in dual antiplatelet therapy as shown by a recent ESC position paper and o...

Full description

Saved in:
Bibliographic Details
Published in:Wiener Klinische Wochenschrift Vol. 130; no. 23-24; pp. 694 - 697
Main Authors: Alber, Hannes F., Huber, Kurt
Format: Journal Article
Language:English
Published: Vienna Springer Vienna 01-12-2018
Subjects:
Endocrinology
Gastroenterology
Internal Medicine
Medicine
Medicine & Public Health
Pneumology/Respiratory System
Review Article
Stable coronary artery disease
P2Y12-inhibitors
Acute coronary syndromes
Atrial fibrillation
Dual antiplatelet therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Duration and compostion of dual antiplatelet therapy has been increasingly changed within the past few years as also indicated in the firmer ESC guidelines. The current manuscript summarizes the most important changes in dual antiplatelet therapy as shown by a recent ESC position paper and offers quick insight into these new developments.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0043-5325
1613-7671
DOI:10.1007/s00508-018-1357-5